Kath. Marienkrankenhaus gGmbH — Hamburg

Public research footprint of Kath. Marienkrankenhaus gGmbH, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Non-Small Cell Lung Cancer (NSCLC) · Head and Neck Squamous Cell Carcinoma · Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer

Recently updated registry entries

NCT06120270 — CeraFlex PFO Closure System PMCF Study (Recruiting)
NCT03155997 — Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in… (Active Not Recruiting)
NCT01630733 — A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Kath. Marienkrankenhaus gGmbH?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.